MphasiS Q1 FY27 earnings call

Mphasis is strategically positioning itself to address the 'Agency Gap' in the market, where enterprises possess AI tools but lack the capability to deploy, govern, and hold AI accountable at scale. The company's Tria platform is central to this strategy, aiming to convert one-time^📎 transformation engagements into repeatable, expanding motions by building enterprise memory and optimizing decision loops. This approach is already showing early traction, with multiple opportunities moving from conversation to closure rapidly, and is elevating client conversations from CIO/CTO levels to broader business agendas.

The company reported strong deal momentum in Q1 FY27, with net new Total Contract Value (TCV) reaching $461 million, marking the fifth consecutive quarter above $400 million. This indicates a higher baseline for deal closures. Mphasis closed three large deals during the quarter, including one valued over $100 million. The total pipeline expanded significantly, growing 8% sequentially and 28% year-over-year, reaching an all-time high. Notably, AI-led deals now constitute 70% of the pipeline, up from 12%, signifying the deep integration of AI into their offerings across all verticals and deal sizes.

For Q1 FY27, Mphasis reported revenues of $471 million, reflecting a 2.1% sequential growth and an 8.3% year-over-year growth in constant currency terms. Direct revenues stood at $465 million, growing 2.2% sequentially and 9.9% YoY in constant currency. However, the EBIT margin experienced a sequential decline of 60 basis points, primarily due to ramp-up costs associated with new deal wins and the integration costs from the TAP acquisition, which alone impacted margins by approximately 35 bps. Consequently, EPS decreased 4% sequentially to INR 25.6.

Mphasis reiterated its FY27 guidance, projecting high single-digit to low double-digit growth in constant currency. The EBIT margin is targeted to remain within the band of 14.75% to 15.75%, balancing platform investments with financial discipline. The company expressed confidence in its Q2 performance, anticipating it to deliver the best sequential constant currency growth in three years, supported by its highest-ever pipeline and robust short-cycle deal activity. Operating cash flow conversion is expected to remain strong at 80% of net income throughout FY27.

The company's Days Sales Outstanding (DSO) for Q1 stood at 95 days, with management expecting a progressive improvement through the remainder of the year. Operating cash flow generation for the quarter was USD 39 million. While the current OCF to EBITDA ratio is around 50%, which is lower than the industry norm, management attributed this to upfront capital investments required for large deals. They anticipate a normalization of this ratio by FY28 as these investments begin to generate incremental cash and past deals unwind.

Americas continued to be the primary growth engine, growing 11.4% YoY and 3.9% sequentially in Direct business. The ROW segment showed a strong sequential recovery with 6.1% QoQ growth in constant currency. Among service lines, Enterprise Applications grew 11.9% YoY, and BPO was a standout with 14% YoY and 12.7% sequential growth, both driven by AI-led propositions. BFS delivered consistent growth at 9.4% YoY and 0.8% sequentially. Insurance, despite a 3.1% sequential decline, grew 17.8% YoY and is expected to be a key growth driver for FY27, while TMT returned to strong growth with 13.6% YoY and 16.4% sequential increases.

Management acknowledged an increasingly fierce competitive intensity in traditional deals, but stated Mphasis is not competing on price. Instead, the company differentiates itself by focusing on bringing AI deployments to life that fundamentally reshape client operations. This involves a forward-leaning deployment model and a shift towards outcome-based pricing, which changes the competitive equation from effort-based pricing. They also noted that large enterprises prefer flexible, plug-and-play AI stacks over native frontier models due to cost and obsolescence risks, aligning with Mphasis's Tria platform strategy.